Download FREE Report Sample
Download Free sampleIntestinal ascariasis is an infection of the small intestine caused by lumbricoides, which is a species of roundworm.
Intestinal Ascariasis Medicine Market contains market size and forecasts of Intestinal Ascariasis Medicine in Global, including the following market information:
Global Intestinal Ascariasis Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Intestinal Ascariasis Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Painkiller Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intestinal Ascariasis Medicine include Pfizer, Actavis, Henan Sino New Energy Material, Bayer HealthCare, Bullvet, Inject Care Parenterals, Endo Pharmaceuticals, Sanofi and Purdue Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intestinal Ascariasis Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intestinal Ascariasis Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Intestinal Ascariasis Medicine Market Segment Percentages, by Type, 2021 (%)
Painkiller
Piperazine Citrate
Complication Treatment Drug
Others
Global Intestinal Ascariasis Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Intestinal Ascariasis Medicine Market Segment Percentages, by Application, 2021 (%)
Patients With Ulcer Disease
Complication Treatment
Others
Global Intestinal Ascariasis Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Intestinal Ascariasis Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intestinal Ascariasis Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Intestinal Ascariasis Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Actavis
Henan Sino New Energy Material
Bayer HealthCare
Bullvet
Inject Care Parenterals
Endo Pharmaceuticals
Sanofi
Purdue Pharma
Novartis
Johnson & Johnson
Cipla
Sun Pharmaceutical Industries
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
